Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1982 Sep;79(17):5175–5178. doi: 10.1073/pnas.79.17.5175

Aminofluorene-DNA adduct formation in Salmonella typhimurium exposed to the carcinogen N-hydroxy-2-acetylaminofluorene.

D T Beranek, G L White, R H Heflich, F A Beland
PMCID: PMC346857  PMID: 6752940

Abstract

The DNA adducts formed during incubation of the hepatocarcinogen N-hydroxy-2-acetylaminofluorene with Salmonella typhimurium tester strain TA1538 were investigated to determine if the covalently bound products were identical to those adducts found in rat liver DNA and to establish the biological significance of the adducts in a mutational assay. When bacteria were exposed to N-hydroxy-2-acetylaminofluorene in the presence of a 9,000 x g supernatant from a rat liver homogenate (S9), only one adduct was detected. This adduct had chromatographic, pH-dependent partitioning, and UV spectral characteristics identical to those of N-(deoxyguanosin-8-yl)-2-aminofluorene. In the absence of S9 activation the same product was detected, but at a 85-90% lower level, which indicates that S. typhimurium also may be capable of metabolizing N-hydroxy-2-acetylaminofluorene to a reactive electrophile. When incubations were conducted with N-hydroxy-2-aminofluorene in the absence of the activation system, N-(deoxyguanosin-8-yl)-2-aminofluorene again was the major adduct. At equimolar concentrations, the arylhydroxylamine was approximately 10 times more efficient than the arylhydroxamic acid in inducing reversions in the bacteria. Comparison of the mutation rate to the level of binding in bacterial DNA gave a linear relationship with a slope of 0.96 and a correlation coefficient of 0.92. These data support previous suggestions that N-hydroxy-2-acetylaminofluorene is deacetylated by rat liver S9 to the ultimate mutagen, N-hydroxy-2-aminofluorene, and also indicate that S. typhimurium can mediate this reaction. The correlation between mutagenicity and the extent of N-(deoxyguanosin-8-yl)-2-aminofluorene adduct formation, coupled with the observation that this adduct is the major DNA adduct found in rat liver in vivo, suggests that N-(deoxyguanosin-8-yl)-2-aminofluorene may be a critical lesion for the initiation of hepatic tumorigenesis.

Full text

PDF
5175

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ames B. N., Durston W. E., Yamasaki E., Lee F. D. Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci U S A. 1973 Aug;70(8):2281–2285. doi: 10.1073/pnas.70.8.2281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ames B. N., Gurney E. G., Miller J. A., Bartsch H. Carcinogens as frameshift mutagens: metabolites and derivatives of 2-acetylaminofluorene and other aromatic amine carcinogens. Proc Natl Acad Sci U S A. 1972 Nov;69(11):3128–3132. doi: 10.1073/pnas.69.11.3128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ames B. N., Mccann J., Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res. 1975 Dec;31(6):347–364. doi: 10.1016/0165-1161(75)90046-1. [DOI] [PubMed] [Google Scholar]
  4. Bartsch H., Malaveille C., Camus A. M., Martel-Planche G., Brun G., Hautefeuille A., Sabadie N., Barbin A., Kuroki T., Drevon C. Validation and comparative studies on 180 chemicals with S. typhimurium strains and V79 Chinese hamster cells in the presence of various metabolizing systems. Mutat Res. 1980 Jul;76(1):1–50. doi: 10.1016/0165-1110(80)90002-0. [DOI] [PubMed] [Google Scholar]
  5. Beland F. A., Allaben W. T., Evans F. E. Acyltransferase-mediated binding of N-hydroxyarylamides to nucleic acids. Cancer Res. 1980 Mar;40(3):834–840. [PubMed] [Google Scholar]
  6. Beland F. A., Dooley K. L., Casciano D. A. Rapid isolation of carcinogen-bound DNA and RNA by hydroxyapatite chromatography. J Chromatogr. 1979 Jun 1;174(1):177–186. doi: 10.1016/s0021-9673(00)87048-x. [DOI] [PubMed] [Google Scholar]
  7. Beland F. A., Dooley K. L., Jackson C. D. Persistence of DNA adducts in rat liver and kidney after multiple doses of the carcinogen N-hydroxy-2-acetylaminofluorene. Cancer Res. 1982 Apr;42(4):1348–1354. [PubMed] [Google Scholar]
  8. DeBaun J. R., Miller E. C., Miller J. A. N-hydroxy-2-acetylaminofluorene sulfotransferase: its probable role in carcinogenesis and in protein-(methion-S-yl) binding in rat liver. Cancer Res. 1970 Mar;30(3):577–595. [PubMed] [Google Scholar]
  9. Drake J. W. Comparative rates of spontaneous mutation. Nature. 1969 Mar 22;221(5186):1132–1132. doi: 10.1038/2211132a0. [DOI] [PubMed] [Google Scholar]
  10. Irving C. C. Enzymatic deacetylation of N-hydroxy-2-acetylaminofluorene by liver microsomes. Cancer Res. 1966 Jul;26(7):1390–1396. [PubMed] [Google Scholar]
  11. Irving C. C., Janss D. H., Russell L. T. Lack of N-hydroxy-2-acetylaminofluorene sulfotransferase activity in the mammary gland and Zymbal's gland of the rat. Cancer Res. 1971 Apr;31(4):387–391. [PubMed] [Google Scholar]
  12. Irving C. C., Veazey R. A. Persistent binding of 2-acetylaminofluorene to rat liver DNA in vivo and consideration of the mechanism of binding of N-hydroxy-2-acetylaminofluorene to rat liver nucleic acids. Cancer Res. 1969 Oct;29(10):1799–1804. [PubMed] [Google Scholar]
  13. Kadlubar F. F., Anson J. F., Dooley K. L., Beland F. A. Formation of urothelial and hepatic DNA adducts from carcinogen 2-naphthylamine. Carcinogenesis. 1981;2(5):467–470. doi: 10.1093/carcin/2.5.467. [DOI] [PubMed] [Google Scholar]
  14. Kaneda S., Seno T., Takeishi K. Species difference in liver microsomal and cytosolic enzymes involved in mutagenic activation of N-hydroxy-N-2-fluorenylacetamide. J Natl Cancer Inst. 1981 Sep;67(3):549–555. [PubMed] [Google Scholar]
  15. King C. M., Phillips B. Enzyme-catalyzed reactions of the carcinogen N-hydroxy-2-fluorenylacetamide with nucleic acid. Science. 1968 Mar 22;159(3821):1351–1353. doi: 10.1126/science.159.3821.1351. [DOI] [PubMed] [Google Scholar]
  16. Kriek E., Miller J. A., Juhl U., Miller E. C. 8-(N-2-fluorenylacetamido)guanosine, an arylamidation reaction product of guanosine and the carcinogen N-acetoxy-N-2-fluorenylacetamide in neutral solution. Biochemistry. 1967 Jan;6(1):177–182. doi: 10.1021/bi00853a029. [DOI] [PubMed] [Google Scholar]
  17. Kriek E. On the interaction of N-2-fluorenylhydroxylamine with nucleic acids in vitro. Biochem Biophys Res Commun. 1965 Sep 22;20(6):793–799. doi: 10.1016/0006-291x(65)90088-4. [DOI] [PubMed] [Google Scholar]
  18. Kriek E. On the mechanism of action of carcinogenic aromatic amines. I. Binding of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene to rat-liver nucleic acids in vivo. Chem Biol Interact. 1969 Oct;1(1):3–17. doi: 10.1016/0009-2797(69)90015-5. [DOI] [PubMed] [Google Scholar]
  19. Kriek E. Persistent binding of a new reaction product of the carcinogen N-hydroxy-N-2-acetylaminofluorene with guanine in rat liver DNA in vivo. Cancer Res. 1972 Oct;32(10):2042–2048. [PubMed] [Google Scholar]
  20. Kriek E., Westra J. G. Structural identification of the pyrimidine derivatives formed from N-(deoxyguanosin-8-yl)-2-aminofluorene in aqueous solution at alkaline pH. Carcinogenesis. 1980 Jun;1(6):459–468. doi: 10.1093/carcin/1.6.459. [DOI] [PubMed] [Google Scholar]
  21. McCann J., Choi E., Yamasaki E., Ames B. N. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc Natl Acad Sci U S A. 1975 Dec;72(12):5135–5139. doi: 10.1073/pnas.72.12.5135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Meerman J. H., Beland F. A., Mulder G. J. Role of sulfation in the formation of DNA adducts from N-hydroxy-2-acetylaminofluorene in rat liver in vivo. Inhibition of N-acetylated aminofluorene adduct formation by pentachlorophenol. Carcinogenesis. 1981;2(5):413–416. doi: 10.1093/carcin/2.5.413. [DOI] [PubMed] [Google Scholar]
  23. Miller E. C. Some current perspectives on chemical carcinogenesis in humans and experimental animals: Presidential Address. Cancer Res. 1978 Jun;38(6):1479–1496. [PubMed] [Google Scholar]
  24. Moore P. D., Koreeda M. Application of the change in partition coefficient with pH to the structure determination of alkyl substituted guanosines. Biochem Biophys Res Commun. 1976 Nov 22;73(2):459–464. doi: 10.1016/0006-291x(76)90729-4. [DOI] [PubMed] [Google Scholar]
  25. Sakai S., Reinhold C. E., Wirth P. J., Thorgeirsson S. S. Mechanism of in vitro mutagenic activation and covalent binding of N-hydroxy-2-acetylaminofluorene in isolated liver cell nuclei from rat and mouse. Cancer Res. 1978 Jul;38(7):2058–2067. [PubMed] [Google Scholar]
  26. Schut H. A., Wirth P. J., Thorgeirsson S. S. Mutagenic activation of N-hydroxy-2-acetylaminofluorene in the Salmonella test system: the role of deacetylation by liver and kidney fractions from mouse and rat. Mol Pharmacol. 1978 Jul;14(4):682–692. [PubMed] [Google Scholar]
  27. Stark A. A., Essigmann J. M., Demain A. L., Skopek T. R., Wogan G. N. Aflatoxin B1 mutagenesis, DNA binding, and adduct formation in Salmonella typhimurium. Proc Natl Acad Sci U S A. 1979 Mar;76(3):1343–1347. doi: 10.1073/pnas.76.3.1343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Stout D. L., Baptist J. N., Matney T. S., Shaw C. R. N'-hydroxy-2-aminofluorene: the principal mutagen produced from N-hydroxy-2-acetylaminofluorene by a mammalian supernatant enzyme preparation. Cancer Lett. 1976 May;1(5):269–274. doi: 10.1016/s0304-3835(75)97640-5. [DOI] [PubMed] [Google Scholar]
  29. Weeks C. E., Allaben W. T., Louie S. C., Lazear E. J., King C. M. Role of arylhydroxamic acid acyltransferase in the mutagenicity of N-hydroxy-N-2-fluorenylacetamide in Salmonella typhimurium. Cancer Res. 1978 Mar;38(3):613–618. [PubMed] [Google Scholar]
  30. Weeks C. E., Allaben W. T., Tresp N. M., Louie S. C., Lazear E. J., King C. M. Effects of structure of N-acyl-N-2-fluorenylhydroxylamines on arylhydroxamic acid acyltransferase, sulfotransferase, and deacylase activities, and on mutations in Salmonella typhimurium TA 1538. Cancer Res. 1980 Apr;40(4):1204–1211. [PubMed] [Google Scholar]
  31. Westra J. G., Kriek E., Hittenhausen H. Identification of the persistently bound form of the carcinogen N-acetyl-2-aminofluorene to rat liver DNA in vivo. Chem Biol Interact. 1976 Oct 2;15(2):149–164. doi: 10.1016/0009-2797(76)90160-5. [DOI] [PubMed] [Google Scholar]
  32. Westra J. G., Visser A. Quantitative analysis of N-(guanin-8-yl)-N-acetyl-2-aminofluorene and N-(guanin-8-yl)-2-aminofluorene in modified DNA by hydrolysis in trifluoroacetic acid and high pressure liquid chromatography. Cancer Lett. 1979 Dec;8(2):155–162. doi: 10.1016/0304-3835(79)90009-0. [DOI] [PubMed] [Google Scholar]
  33. Wirth P. J., Thorgeirsson S. S. Mechanism of N-hydroxy-2-acetylaminofluorene mutagenicity in the Salmonella test system. Role of N-O acyltransferase and sulfotransferase from rat liver. Mol Pharmacol. 1981 Mar;19(2):337–344. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES